Top FDA officials have spelled out their strategic priorities in the coming years, including the use of AI to "increase efficiency".

Reports say Novo Nordisk may have inadvertently let generics of its GLP-1 drug semaglutide for diabetes and obesity launch in Canada early next year.

UNITED LATEST Man Utd transfer news LIVE: Sesko set for MEDICAL as United reach agreement, Baleba contact made, Garnacho talks advance ...